MedPath

National Cancer Center Korea

National Cancer Center Korea logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1989-01-01
Employees
-
Market Cap
-
Website
http://www.ncc.re.kr

Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2008-02-21
Last Posted Date
2013-06-19
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
25
Registration Number
NCT00620347
Locations
🇰🇷

National Cancer Center, Korea, Goyang-si, Gyeonggi-do, Korea, Republic of

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

Phase 2
Conditions
Lung Cancer
NSCLC
Interventions
Drug: Induction or consolidation IP chemotherapy
Radiation: CCRT
Drug: CCRT with IP chemotherapy (Irinotecan + Cisplatin)
First Posted Date
2008-02-21
Last Posted Date
2011-11-06
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
212
Registration Number
NCT00620269
Locations
🇰🇷

National Cancer Center, Korea, Goyang-si, Gyenggi-do, Korea, Republic of

Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer

Phase 2
Conditions
Stomach Neoplasms
First Posted Date
2008-01-07
Last Posted Date
2008-01-07
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
44
Registration Number
NCT00587145
Locations
🇰🇷

National Cancer Center Korea, Goyang,, Gyeonggi, Korea, Republic of

S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

Phase 2
Conditions
Stomach Neoplasms
Interventions
First Posted Date
2007-12-24
Last Posted Date
2008-01-08
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
96
Registration Number
NCT00580359
Locations
🇰🇷

National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of

Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301)

Phase 3
Completed
Conditions
Gastric Cancer
Interventions
Procedure: laparoscopy assisted distal gastrectomy
Procedure: Open distal gastrectomy
First Posted Date
2007-10-19
Last Posted Date
2012-05-24
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
164
Registration Number
NCT00546468
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggi-do, Korea, Republic of

Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC

Phase 2
Completed
Conditions
Breast Cancer Metastatic
Interventions
First Posted Date
2007-09-20
Last Posted Date
2011-12-30
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
36
Registration Number
NCT00532714
Locations
🇰🇷

National Cancer Center, 809 Madu1-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea, Republic of

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC

Phase 2
Completed
Conditions
Metastatic Breast Cancer
Interventions
First Posted Date
2007-09-20
Last Posted Date
2011-06-27
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
78
Registration Number
NCT00532272
Locations
🇰🇷

National Cancer Center, Goyang, Korea, Republic of

Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer

Phase 2
Completed
Conditions
Metastatic Breast Cancer
Interventions
First Posted Date
2007-09-20
Last Posted Date
2011-06-27
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
82
Registration Number
NCT00532623

Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer

Phase 2
Terminated
Conditions
Breast Cancer
Interventions
Drug: Paclitaxel/Gemcitabine
First Posted Date
2007-09-20
Last Posted Date
2011-06-23
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
44
Registration Number
NCT00532285

Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

Phase 2
Terminated
Conditions
Breast Cancer
Metastatic Disease
Interventions
First Posted Date
2007-09-20
Last Posted Date
2010-02-10
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
21
Registration Number
NCT00532454
Locations
🇰🇷

National Cancer Center, 809 Madu1-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea, Republic of

🇰🇷

National cancer center, Goyang-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath